The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nimotop 0.02% w/v Concentrate for Solution for Infusion

Bayer LimitedPA1410/030/002

Main Information

Trade NameNimotop 0.02% w/v Concentrate for Solution for Infusion
Active SubstancesNimodipine
Dosage FormConcentrate for solution for infusion
Licence HolderBayer Limited
Licence NumberPA1410/030/002

Group Information

ATC CodeC08CA Dihydropyridine derivatives
C08CA06 nimodipine


License statusAuthorised
Licence Issued15/02/1994
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back